Stanford-UCSF evidence-based practice center, comparative effectiveness of in-hospital use of recombinant factor VIIa for off-label indications vs. usual care, comparative effectiveness review No. 21, prepared under Contract No. 290-02-0017 for the Agency for Healthcare Research and Quality (2010)
[cited 2011 Jan 5]. Available from: